Cancer APIs and Clinical Trials

The Active Pharmaceutical Ingredient (API) is the part of any drug that is biologically active. All drugs are made up of two core components: the API, which is the central ingredient, and the excipients (chemically inactive substances such as lactose or mineral oil) that help deliver the medication to our system. Abiraterone acetate, Anastrozole, Bendamustine are few names among the anti-cancer API products.

The end step in a long process that begins in a research lab is Clinical Trials. After many years of research work to understand its effects on cancer cells in the lab and in animals, a new treatment is used for people in clinical trials.

Through clinical trials, doctors determine whether the new treatments are safe and effective and work better than current treatments. It helps in finding new ways to prevent and detect cancer and also to improve the quality of life for people during and after treatment.

    Related Conference of Cancer APIs and Clinical Trials

    Cancer APIs and Clinical Trials Conference Speakers